These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3872195)

  • 21. [The effectiveness of so-called potentiated penicillins (augmentin and tazobactam) in vitro].
    Blahová J; Hupková M; Krcméry V
    Cas Lek Cesk; 1995 Sep; 134(17):558-61. PubMed ID: 7553760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of lomefloxacin (SC 47111 or NY-198) against isolates of Legionella spp.
    Dubois J; Joly JR
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):89S-91S. PubMed ID: 2791504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of the bactericidal activity of ampicillin/sulbactam and erythromycin against intracellular Legionella pneumophila.
    Ramirez JA; Summersgill JT; Miller RD; Meyers TL; Raff MJ
    J Antimicrob Chemother; 1993 Jul; 32(1):93-9. PubMed ID: 8226420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-disk synergy test positivity in Stenotrophomonas maltophilia clinical strains.
    Hejnar P; Kolár M; Chmela Z
    Folia Microbiol (Praha); 2004; 49(1):71-4. PubMed ID: 15114869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor.
    Aswapokee N; Neu HC
    J Antibiot (Tokyo); 1978 Dec; 31(12):1238-44. PubMed ID: 310815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
    Jacobs MR; Aronoff SC; Johenning S; Yamabe S
    J Antimicrob Chemother; 1986 Aug; 18(2):177-84. PubMed ID: 3019984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
    Doern GV; Chapin KC
    Diagn Microbiol Infect Dis; 1986 Jan; 4(1):37-41. PubMed ID: 3484692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
    Vanjak D; Muller-Serieys C; Picard B; Bergogne-Berezin E; Lambert-Zechovsky N
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-kill kinetic studies of ampicillin/sulbactam for beta-lactamase-producing enterococci.
    Patterson JE; Farrel P; Zervos MJ
    Diagn Microbiol Infect Dis; 1991; 14(6):495-9. PubMed ID: 1802536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC; Barry AL
    J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Zhang D; Wang Y; Lu J; Pang Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):393-9. PubMed ID: 26525785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships of 6-(heterocyclyl)-methylene penam sulfones; a new class of beta-lactamase inhibitors.
    Chen YL; Chang CW; Hedberg K; Guarino K; Welch WM; Kiessling L; Retsema JA; Haskell SL; Anderson M; Manousos M
    J Antibiot (Tokyo); 1987 Jun; 40(6):803-22. PubMed ID: 3497142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibition.
    Barry AL; Jones RN; Thornsberry C
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):7-17. PubMed ID: 3871382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbiological properties of sulbactam combined with ampicillin.
    Barba D; Galante D; Esposito S; Ruffilli MP
    Chemioterapia; 1987 Apr; 6(2):88-94. PubMed ID: 3036381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergy of clavulanic acid, sulbactam and tazobactam (YTR 830) with amoxycillin against fifty beta-lactamase-producing strains of Haemophilus influenzae.
    Simonet M; Moittie D; Philippon A; Descamps P; Veron M
    J Antimicrob Chemother; 1989 May; 23(5):798-800. PubMed ID: 2547748
    [No Abstract]   [Full Text] [Related]  

  • 38. In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
    Barry AL; Jones RN; Packer RR
    J Antimicrob Chemother; 1986 Jan; 17(1):125-7. PubMed ID: 3005222
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of single and combined antibiotics on the growth of Legionella pneumophila using time-kill studies.
    Barker JE; Farrell ID
    J Antimicrob Chemother; 1990 Jul; 26(1):45-53. PubMed ID: 2211446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of clavulanic acid on minimal inhibitory concentrations of 16 antimicrobial agents tested against Legionella pneumophila.
    Pohlod DJ; Saravolatz LD; Quinn EL; Somerville MM
    Antimicrob Agents Chemother; 1980 Aug; 18(2):353-4. PubMed ID: 6969575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.